These results suggest that YWHAE interacts with TRIP13 and is involved in ERK/MAPK signaling and that DCZ5417, a TRIP13 inhibitor, can inhibit this signaling in MM. The gene discussed is YWHAE; the disease is Miyoshi myopathy.